Gemini Bioproducts Holding
West Sacramento, US · Founded 2018 · Delaware corporation
Founders & leadership
BP
Brian ParkerExecutive
JW
Joseph WynneExecutive
EM
Edwin MendhamExecutive
Board
CS
Cory StevensonBoard director
DD
Dennis DrislaneBoard director
GN
Gopi NatajaranBoard director
MG
Michael GuerraBoard director
AL
Arthur LafferBoard director
SS
Steven Sandoval, Sr.Board director
HB
Harold BlueBoard director
GN
Gopi NatarajanBoard director
BP
Bryan PoltiloveBoard director
Reported raises · per SEC filings
Form D private placements$25.7M disclosed across 4 rounds · 2022–2024
▶$5.7MraisedNov 2024 · 21 investors · ManufacturingRule 506(b)
▶$5.7MraisedNov 2024 · 21 investors · Manufacturing
Rule 506(b)Officers, directors & promoters on the filing
- Michael GuerraDirector
- Brian ParkerExecutive Officer, Director
- Arthur LafferDirector
- Steven Sandoval, Sr.Director
- Harold BlueDirector
- Joseph WynneExecutive Officer
- Gopi NatarajanDirector
- Cory StevensonDirector
- Bryan PoltiloveDirector
- Edwin MendhamExecutive Officer
- Dennis DrislaneDirector
- Offering amount
- $7M
- Amount sold
- $5.7M
- Minimum investment
- $100K
- First sale
- May 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.5MraisedSep 2023 · 7 investors · ManufacturingRule 506(b)
▶$1.5MraisedSep 2023 · 7 investors · Manufacturing
Rule 506(b)Officers, directors & promoters on the filing
- Brian ParkerExecutive Officer, Director
- Edwin MendhamExecutive Officer
- Cory StevensonDirector
- Arthur LafferDirector
- Dennis DrislaneDirector
- Harold BlueExecutive Officer, Director
- Gopi NatajaranDirector
- Bryan PoltiloveDirector
- Joseph WynneExecutive Officer
- Offering amount
- $1.5M
- Amount sold
- $1.5M
- Minimum investment
- $50K
- First sale
- Sep 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3.5MraisedApr 2023 · 13 investors · ManufacturingRule 506(b)
▶$3.5MraisedApr 2023 · 13 investors · Manufacturing
Rule 506(b)Officers, directors & promoters on the filing
- Cory StevensonDirector
- Brian ParkerExecutive Officer, Director
- Edwin MendhamExecutive Officer
- Gopi NatajaranDirector
- Harold BlueExecutive Officer, Director
- Dennis DrislaneDirector
- Joseph WynneExecutive Officer
- Arthur LafferDirector
- Offering amount
- $3.5M
- Amount sold
- $3.5M
- Minimum investment
- $50K
- First sale
- Mar 2023
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$15MraisedMay 2022 · 21 investors · ManufacturingRule 506(b)
▶$15MraisedMay 2022 · 21 investors · Manufacturing
Rule 506(b)Officers, directors & promoters on the filing
- Harold BlueExecutive Officer, Director
- Brian ParkerDirector
- Dennis DrislaneDirector
- Joseph WynneExecutive Officer
- Anthony Scott LeeExecutive Officer, Director
- Ted AyliffeDirector
- Arthur LafferDirector
- Offering amount
- $15M
- Amount sold
- $15M
- Minimum investment
- $50K
- First sale
- May 2022
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Gemini Bioproducts Holding raised?
- Gemini Bioproducts Holding has disclosed $25.7M raised across 4 rounds.
- Where is Gemini Bioproducts Holding headquartered?
- Gemini Bioproducts Holding is headquartered in West Sacramento, US.